Mayo Clinic Q&A: What is pharmacogenomics?
DEAR MAYO CLINIC: I’ve been hearing a lot about lab tests that can look at my genetics to see how I metabolize medications. How does this…
Study: T cells in rheumatoid arthritis have damaged mitochondria
Mayo Clinic researchers have linked the T cell dysfunction seen in rheumatoid arthritis with a metabolic deficiency, according to a new publication in Nature Immunology. In…
Triggering the body’s ability to heal
Erwin Kruger, M.D. — a Mayo Clinic surgeon who’s leading a Medicare claims study that uses people’s own blood to create a medical patch to…
Mayo Clinic researchers: ‘Our goal is to achieve a world without viral hepatitis’
Viral hepatitis, or inflammation of the liver, is one of the most common infectious diseases in the world. Hundreds of millions of people live with…
A new, shorter treatment for HPV-associated oral cancer
Mayo Clinic researchers have found that a new, shorter treatment for patients with HPV-associated oropharynx cancer leads to excellent disease control and fewer side effects,…
Bad fat, misbehaving kidneys may share common offender
In a recent paper published in Cell Reports, Mayo Clinic scientists found that a sensory device on cells determines if a fat cell burns fat or…
Winter, holidays and keeping safe from COVID-19 and other viruses
As the end of the year approaches, it’s only the beginning of the season for illnesses like the cold and flu. Add COVID-19 and other viruses to the list,…
COVID Conversations: Experts urge COVID-19 boosters to fight omicron surge
In a podcast recorded for the Mayo Clinic News Network, Gregory Poland, M.D., discuses the latest information on COVID-19 variants and shares advice on how…
Mayo Clinic Q and A: Knee reconstruction in younger patients
DEAR MAYO CLINIC: I am 35 and have had various knee issues for a few years. I’m a runner and played other sports. My primary care…
Biological age and other AI tools in preventive cardiology
Doctors have observed for many years that people age at different speeds, according to Dr. Francisco Lopez-Jimenez, chair of preventive cardiology at Mayo Clinic in…
Mayo Clinic Q&A podcast: Post COVID-19 syndrome can be a long haul
Most people who have COVID-19 recover completely within a few weeks. But some people — even those who had mild versions of the disease —…
Testing for COVID-19 at home
The emergence of a new COVID-19 variant, omicron, has heightened safety protocols and plans to help people stay safe from illness as researchers and experts learn more about…
HIV research provided foundation for COVID-19 research
This year’s World AIDS Day will be commemorated on Dec. 1. It was 40 years ago in June that the first scientific report was made describing pneumocystis pneumonia, which later…
Mayo Clinic Q&A podcast: Boosters reduce vulnerability to COVID-19 variants
Omicron, a new COVID-19 variant of concern, has been detected in all regions of the world, including North America. While research and clinical observations on the new…
COVID-19 pill gets advisory panel approval
The first oral antiviral medication to treat COVID-19 is one step closer. A Food and Drug Administration (FDA) advisory panel has voted to recommend emergency use authorization…
The dawning of regenerative neurosurgery
Regenerative neurosurgery is poised to transform care of neurological disorders that previously had little hope for improvement, according to a Mayo Clinic review published in The BMJ. Healing…
A robotic GPS for targeting, delivering regenerative biotherapies
A remote-controlled bronchoscope that acts like a GPS system hunts down hard to find lung masses and accurately biopsies them, according to a Mayo Clinic…
Colorectal cancer screening aims younger: 45 is the new 50
Millions of people who thought colorectal cancer screening was somewhere off in their distant future recently got a wake-up call. The recommended age for taking…
Fruit flies help Mayo Clinic researchers look for ways to protect nerve cells from chemotherapy
Fishing them out of a drink, you may not see the benefit of fruit flies. But they are a vital scientific model, and at Mayo…
How clinical trials work: COVID-19 and beyond
Clinical trials follow rigorous scientific processes that usually take many years to complete. However, during the COVID-19 pandemic, clinical trials are operating on fast-forward. In…
What’s new in regenerative medicine research for neurodegenerative diseases
The cells in the brain and spinal cord don’t replace themselves after they’ve been injured, such as from a neurodegenerative disease like Parkinson’s, or as…
The innovative research behind HIV/AIDS treatment
It’s been 40 years since the release of the first scientific report describing acquired immune deficiency syndrome (AIDS). Thanks to innovative research, scientists learned how…
Fatigue that won’t stop: COVID-19 long-hauler syndrome
Experts estimate that 10 percent to 30 percent of people who have had COVID-19 experience fatigue and other symptoms many months after initial infection. In…
Study finds colon cancer driven by hereditary gene mutations in 1 in 6 patients
A new Mayo Clinic study bolsters evidence that colorectal cancer is often imprinted in family genes and passed on from one generation to the next.…
Instigator gene associated with Alzheimer’s disease identified
In a new paper published in Nature Communications, Mayo Clinic researchers and collaborators report the protein-coding gene SERPINA5 may worsen tau protein tangles, which are…
Study finds lung transplant patients given antifungal preventive drugs have lower risk of death
Antifungal preventive medications reduce mortality risk by half in the first year following lung transplantation, according to Mayo Clinic research involving 667 patients who received…